GLP-1 drugs have captured global attention, but they come with limitations — tolerability issues, muscle mass loss, and ...
InvestorsHub on MSN
BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform
BioRestorative Therapies, Inc. (NASDAQ:BRTX) said Tuesday that Australia’s intellectual property authority has approved a key patent application covering its ThermoStem® technology, expanding global ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results